Welcome and Overview – Michael M. Awad, MD, PhD & Ivy Haskins, MD Surgical Critical Care/Trauma – Maggie Bosley, MD Breast/Endocrine – Amy Rosenbluth, MD Miscellaneous – Sara Hennessy, MD Vascular – Vipul Khetaurpaul, MD
Treatment with vedolizumab or ustekinumab in CD, or vedolizumab in UC, followed by an anti–TNF was found to be safe.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are known to cause delayed gastric emptying; however, the effect on clinical outcomes during upper endoscopy and colonoscopy remains unclear.…
Chronic hepatitis D (CHD) is the most severe form of viral hepatitis, carrying a greater risk of developing cirrhosis and its complications. For decades, pegylated…
Background GI cancers pose an increasing global health burden, with their impact on the working-age population (WAP) aged 15–64 years remaining largely unexplored despite the…
Join us to hear directly from the experts! This Gastro Bites session provides the opportunity to gain valuable insights and ask questions directly to the…
In this webinar, explore how patient navigation services enhance lung cancer care by guiding patients through each step of the care continuum, from screening to…
Infection is formally recognised as an infectious disease, an entity that is now included in the International Classification of Diseases 11th Revision. This in principle…
Objective The specific breast milk-derived metabolites that mediate host–microbiota interactions and contribute to the onset of atopic dermatitis (AD) remain unknown and require further investigation.…
Background Cholangiocarcinoma (CCA) is a very difficult-to-treat cancer. Chemotherapies are little effective and response to immune checkpoint inhibitors is limited. Therefore, new therapeutic strategies need…
